Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BAQSIMI safely and effectively. See full prescribing information for BAQSIMI. BAQSIMI (glucagon) nasal powder Initial U.S. Approval: 1960
Medication labelWhy this: Advisory · dailymed-prescription
BAQSIMI™ is indicated for the treatment of severe hypoglycemia in adults and pediatric patients aged 1 year and older with diabetes.
- generic_name
- glucagon
- product_names
- glucagon
- ndc
- 85766-212, 0548-8351, 85766-212-03
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en